Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  recombinant human hyaluronidase
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
A Study of Daratumumab With the Addition of Recombinant Human Hyaluronidase (rHuPH20) for the Treatment of Participants With Relapsed or Refractory Multiple Myeloma
Status: Active
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CR107838, NCI-2016-00594, 2015-001210-94, NCT02519452
Start Over